Hypertension in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma in ALPINE: a secondary analysis.

Blood Neoplasia · 2025 · PMC12711688 · PMID 41424932

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

did not reach statistical significanceP = .071so close (0.05 < p ≤ 0.1)

Time to initiation of antihypertensive therapy Among all patients, differences in cumulative event rates for time to initiation of a new antihypertensive therapy in the zanubrutinib arm vs ibrutinib arm did not reach statistical significance (hazard ratio [HR] = 0.77, P = .071; Figure 4 A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.